Aldo Cuccia

509 total citations
19 papers, 269 citations indexed

About

Aldo Cuccia is a scholar working on Immunology, Dermatology and Hematology. According to data from OpenAlex, Aldo Cuccia has authored 19 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Dermatology and 4 papers in Hematology. Recurrent topics in Aldo Cuccia's work include Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (7 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Aldo Cuccia is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (9 papers), Dermatology and Skin Diseases (7 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Aldo Cuccia collaborates with scholars based in Italy, Spain and Switzerland. Aldo Cuccia's co-authors include Paolo Sbano, Michele Fimiani, Pietro Rubegni, Alberto Bosi, G. De Aloe, G. Pompella, Clelia Miracco, Francesca Torricelli, Serena Urbani and Luciana Rossi and has published in prestigious journals such as British Journal of Haematology, British Journal of Dermatology and European Journal of Neurology.

In The Last Decade

Aldo Cuccia

17 papers receiving 266 citations

Peers

Countries citing papers authored by Aldo Cuccia

Since Specialization

Citations

This map shows the geographic impact of Aldo Cuccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Cuccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Cuccia more than expected).

Fields of papers citing papers by Aldo Cuccia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldo Cuccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Cuccia. The network helps show where Aldo Cuccia may publish in the future.

Co-authorship network of co-authors of Aldo Cuccia

This figure shows the co-authorship network connecting the top 25 collaborators of Aldo Cuccia. A scholar is included among the top collaborators of Aldo Cuccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldo Cuccia. Aldo Cuccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Effectiveness of Tildrakizumab 200 mg in Moderate-to-Severe Plaque Psoriasis: A Multicenter Real-World Study Analyzing Patient Outcomes by Weight, PASI, BMI, and Previous Therapies 2025 ·Dermatology and Therapy ·Emanuele Trovato, Tommaso Bianchelli, Giulia Odorici, Aldo Cuccia, Vito Di Lernia, Claudia Lasagni, Marco Manfredini, (unknown), Giulia Rech, Francesca Satolli, Alessandra Cartocci, Federico Bardazzi, Anna Campanati	0
2	Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 2023 ·Vaccines ·Francesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, Stefano Piaserico, Clara De Simone, Giovanni Damiani, Giuseppe Argenziano, Marina Venturini, Paolo Dapavo, Antonio Costanzo, Matteo Megna, Francesca Prignano, Martina Burlando, Francesca Satolli, Andrea Carugno, Elena Pezzolo, Marco Romanelli, Aldo Cuccia, Giampiero Girolomoni	7
3	Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate‐to‐severe plaque psoriasis patients in conditions close to clinical practice 2023 ·Journal of the European Academy of Dermatology and Venereology ·Antonio Costanzo, Mar Llamas‐Velasco, Gabriella Fabbrocini, Aldo Cuccia, (unknown), Kristian Gaarn du Jardin, Ismail Kasujee, L. Puig, J.M. Carrascosa	13
4	Pso-Reg: a web registry for psoriasis in real life 2023 ·Italian Journal of Dermatology and Venereology ·Emanuele Trovato, Alessandra Cartocci, Laura Calabrese, Martina D’Onghia, (unknown), (unknown), (unknown), (unknown), Nicola Pimpinelli, Michele Pellegrino, Marco Romanelli, (unknown), Aldo Cuccia, Carlo Mazzatenta, Pietro Rubegni, Francesca Prignano	2
5	Real-world use of dimehtyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus 2022 ·Dermatology Reports ·Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi	3
6	Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics 2022 ·Italian Journal of Dermatology and Venereology ·Francesca Prignano, Leonardo Pescitelli, Emanuele Trovato, Antonella Di Cesare, Aldo Cuccia, Carlo Mazzatenta, Michele Pellegrino, (unknown), Antonio Castelli, (unknown), (unknown), (unknown), Federica Ricceri, Salvatore Panduri, Gionata Buggiani, Alberto Ghilardi, Pietro Rubegni, Marco Romanelli, Nicola Pimpinelli	3
7	Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study 2021 ·Journal of Dermatological Treatment ·Federica Ricceri, Federico Bardazzi, Gionata Buggiani, Martina Burlando, Elena Campione, Monica Corazza, Aldo Cuccia, Paolo Dapavo, (unknown), Leonardo Zichichi, Aurora Parodi, Francesca Prignano	7
8	Effectiveness of cyclosporine A in patients with moderate to severe plaque psoriasis in a real-life clinical setting in Italy: the TRANSITION study 2020 ·Journal of Dermatological Treatment ·(unknown), (unknown), Giuseppe Stinco, (unknown), R. Tiberio, Francesca Prignano, Annamaria Mazzotta, (unknown), Aldo Cuccia, (unknown), Maria Rita Bongiorno, Severino Persechino, Tullio Florio, (unknown), (unknown), (unknown), (unknown), Marta Bartezaghi, R. Orsenigo	7
9	Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results 2020 ·Journal of the European Academy of Dermatology and Venereology ·Matthias Augustin, E. Daudén, Ulrich Mrowietz, Maria Polina Konstantinou, Sascha Gerdes, Külli Kingo, Jacek C. Szepietowski, J.-L. Perrot, Aldo Cuccia, Michael Rissler, (unknown), Christian Sieder, R. Orsenigo, (unknown), Teresa Bachhuber	18
10	Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model 2008 ·Archives of Dermatological Research ·Paolo Sbano, Aldo Cuccia, Benedetta Mazzanti, Serena Urbani, Betti Giusti, Ilaria Lapini, Luciana Rossi, Rosanna Abbate, Giuseppina Marseglia, (unknown), Francesca Torricelli, Clelia Miracco, Alberto Bosi, Michele Fimiani, Riccardo Saccardi	79
11	Hypohidrotic Ectodermal Dysplasia and Intrathoracic Neuroblastoma 2007 ·Pediatric Dermatology ·Sabrina Buoni, Raffaella Zannolli, (unknown), (unknown), (unknown), Aldo Cuccia, Joussef Hayek, Luca Volterrani, Maria Margherita De Santi, Clelia Miracco, A. Fois	2
12	Neurocutaneous syndrome with mental delay, autism, blockage in intracellular vescicular trafficking and melanosome defects 2006 ·European Journal of Neurology ·Sabrina Buoni, Raffaella Zannolli, (unknown), (unknown), Joussef Hayek, A Orsi, (unknown), (unknown), Aldo Cuccia, Michele Zappella, Clelia Miracco	3
13	Role of extracorporeal photochemotherapy in patients with refractory chronic graft‐versus‐host disease 2005 ·British Journal of Haematology ·Pietro Rubegni, Aldo Cuccia, Paolo Sbano, Gabriele Cevenini, (unknown), (unknown), G. De Aloe, S. Guidi, P Guglielmetti, Giuseppe Marotta, Francesco Lauria, Alberto Bosi, Michele Fimiani	44
14	Other uses of homologous skin grafts and skin bank bioproducts 2005 ·Clinics in Dermatology ·Michele Fimiani, Elisa Pianigiani, (unknown), Paolo Sbano, Aldo Cuccia, G. Pompella, G. De Aloe, Felice Petraglia	22
15	Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease 2005 ·British Journal of Dermatology ·M. Di Renzo, Pietro Rubegni, Anna Laura Pasqui, G. Pompella, G. De Aloe, Paolo Sbano, Aldo Cuccia, Cinzia Castagnini, A. Auteri, (unknown), Michele Fimiani	28
16	Acral Malignant Melanoma and Striated Palmoplantar Keratoderma (Brunauer-Fohs-Siemens Syndrome): A Fortuitous Association? 2004 ·Dermatologic Surgery ·Pietro Rubegni, S. Poggiali, Aldo Cuccia, M. Biagioli, Michele Fimiani	3
17	ECP-treated lymphocytes of chronic graft-versus-host disease patients undergo apoptosis which involves both the Fas/FasL system and the Bcl-2 protein family 2003 ·Archives of Dermatological Research ·M. Di Renzo, Pietro Rubegni, Paolo Sbano, Aldo Cuccia, Cinzia Castagnini, G. Pompella, A. L. Pasqui, Pier Leopoldo Capecchi, A. Auteri, (unknown), Michele Fimiani	17
18	An unusual case of tinea capitis due to Trichophyton soudanense 2003 ·Mycoses ·Clara Romano, Clelia Miracco, Elisabetta Faggi, Aldo Cuccia, Gian Andrea Pini	1
19	Digital dermoscopy analysis of atypical pigmented skin lesions: a stepwise logistic discriminant analysis approach 2002 ·Skin Research and Technology ·Pietro Rubegni, Gabriele Cevenini, Marco Burroni, Giordana Dell’Eva, Paolo Sbano, Aldo Cuccia, Lucio Andreassi	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact